Compare Duolingo Inc (DUOL) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Edwards Lifesciences Corporation Common Stock — how do they compare? Duolingo Inc trades at $148.99 (market cap $7.08B), while Edwards Lifesciences Corporation Common Stock trades at $83.86 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 6.9× Duolingo Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals.
| DUOL | EW | |
|---|---|---|
Market Cap | $7.08B | $48.56B |
Volume | 729,171 | 6,520,488 |
Sector | Technology | Health |
52-Week High | $341.08 | $95.18 |
52-Week Low | $90.03 | $72.65 |
Typical Hold Time | 137 Days | — |
Enterprise Value | $5.85B | $45.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $150.50, down 0.8% on the day, as the stock consolidates near key resistance at $151. The company demonstrates strong fundamental momentum with revenue reaching $1.04 billion in 2025 and net income surging to $414 million, representing a robust 39.9% margin. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $0.66 exceeding the $0.604 forecast. Technical indicators show a bullish moving average alignment while RSI levels suggest potential near-term consolidation.
Duolingo presents a compelling growth story with accelerating profitability and strong user engagement, though valuation multiples remain elevated. Key risks include increased competition in edtech and insider selling activity. Analyst consensus leans cautious with a $140.63 price target below current levels, suggesting potential near-term headwinds despite the company's operational excellence.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
